These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 21038414

  • 21. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
    Benedetti A, Alvaro D, Bassotti C, Gigliozzi A, Ferretti G, La Rosa T, Di Sario A, Baiocchi L, Jezequel AM.
    Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
    [Abstract] [Full Text] [Related]

  • 22. Role of perivenous hepatocytes in taurolithocholate-induced cholestasis in vivo.
    Mottino A, Tuchweber B, Plaa GL, Yousef IM.
    Toxicol Lett; 2000 Jul 27; 116(1-2):69-77. PubMed ID: 10906424
    [Abstract] [Full Text] [Related]

  • 23. Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat.
    Rodríguez-Ortigosa CM, Banales JM, Olivas I, Uriarte I, Marín JJ, Corrales FJ, Medina JF, Prieto J.
    Hepatology; 2010 Aug 27; 52(2):667-77. PubMed ID: 20683964
    [Abstract] [Full Text] [Related]

  • 24. 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
    Clerici C, Castellani D, Asciutti S, Pellicciari R, Setchell KD, O'Connell NC, Sadeghpour B, Camaioni E, Fiorucci S, Renga B, Nardi E, Sabatino G, Clementi M, Giuliano V, Baldoni M, Orlandi S, Mazzocchi A, Morelli A, Morelli O.
    Toxicol Appl Pharmacol; 2006 Jul 15; 214(2):199-208. PubMed ID: 16487557
    [Abstract] [Full Text] [Related]

  • 25. Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver.
    Macias RI, Jimenez S, Serrano MA, Monte MJ, Marin JJ.
    Life Sci; 2006 Aug 01; 79(10):1014-9. PubMed ID: 16764892
    [Abstract] [Full Text] [Related]

  • 26. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
    Hillaire S, Ballet F, Franco D, Setchell KD, Poupon R.
    Hepatology; 1995 Jul 01; 22(1):82-7. PubMed ID: 7601437
    [Abstract] [Full Text] [Related]

  • 27. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.
    Perez MJ, Macias RI, Duran C, Monte MJ, Gonzalez-Buitrago JM, Marin JJ.
    J Hepatol; 2005 Aug 01; 43(2):324-32. PubMed ID: 15970352
    [Abstract] [Full Text] [Related]

  • 28. Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate.
    Rudolph G, Kloeters-Plachky P, Sauer P, Stiehl A.
    Eur J Clin Invest; 2002 Aug 01; 32(8):575-80. PubMed ID: 12190957
    [Abstract] [Full Text] [Related]

  • 29. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
    Macias RI, Serrano MA, Monte MJ, Jimenez S, Hernandez B, Marin JJ.
    J Pharmacol Exp Ther; 2005 Feb 01; 312(2):751-8. PubMed ID: 15452192
    [Abstract] [Full Text] [Related]

  • 30. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.
    Mizoguchi Y, Miyajima K, Kioka K, Seki S, Kobayashi K, Morisawa S.
    Osaka City Med J; 1989 Nov 01; 35(2):83-91. PubMed ID: 2628845
    [Abstract] [Full Text] [Related]

  • 31. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies.
    Barone M, Francavilla A, Polimeno L, Ierardi E, Romanelli D, Berloco P, Di Leo A, Panella C.
    Hepatology; 1996 May 01; 23(5):1159-66. PubMed ID: 8621149
    [Abstract] [Full Text] [Related]

  • 32. UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications.
    Cabrera D, Arab JP, Arrese M.
    Handb Exp Pharmacol; 2019 May 01; 256():237-264. PubMed ID: 31236688
    [Abstract] [Full Text] [Related]

  • 33. 24-Norursodeoxycholic acid reshapes immunometabolism in CD8+ T cells and alleviates hepatic inflammation.
    Zhu C, Boucheron N, Müller AC, Májek P, Claudel T, Halilbasic E, Baazim H, Lercher A, Viczenczova C, Hainberger D, Preglej T, Sandner L, Alteneder M, Gülich AF, Khan M, Hamminger P, Remetic J, Ohradanova-Repic A, Schatzlmaier P, Donner C, Fuchs CD, Stojakovic T, Scharnagl H, Sakaguchi S, Weichhart T, Bergthaler A, Stockinger H, Ellmeier W, Trauner M.
    J Hepatol; 2021 Nov 01; 75(5):1164-1176. PubMed ID: 34242699
    [Abstract] [Full Text] [Related]

  • 34. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A, Rudolph G, Sauer P, Theilmann L.
    J Hepatol; 1995 Sep 01; 23(3):283-9. PubMed ID: 8550992
    [Abstract] [Full Text] [Related]

  • 35. Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease.
    Lirussi F, Okolicsanyi L.
    Ital J Gastroenterol; 1992 Jan 01; 24(1):31-5. PubMed ID: 1571577
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Bile acids in liver diseases--current indications].
    Stiehl A.
    Ther Umsch; 1995 Oct 01; 52(10):682-6. PubMed ID: 7482380
    [Abstract] [Full Text] [Related]

  • 38. Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action.
    Poupon R.
    Clin Res Hepatol Gastroenterol; 2012 Sep 01; 36 Suppl 1():S3-12. PubMed ID: 23141891
    [Abstract] [Full Text] [Related]

  • 39. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate.
    Rost D, Herrmann T, Sauer P, Schmidts HL, Stieger B, Meier PJ, Stremmel W, Stiehl A.
    Hepatology; 2003 Jul 01; 38(1):187-95. PubMed ID: 12830001
    [Abstract] [Full Text] [Related]

  • 40. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.
    Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F, Marschall HU, Tsybrovskyy O, Zatloukal K, Denk H, Trauner M.
    Gastroenterology; 2002 Oct 01; 123(4):1238-51. PubMed ID: 12360485
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.